Generation of Dendritic cells from patients with breast cancer, multiple myeloma or ovarian cancer

Generation of Dendritic cells from patients with breast cancer, multiple myeloma or ovarian cancer - Production of Dendritic cells from patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON33883

Enrollment

Registered

2009-07-15

Start date

2010-06-15

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Multiple Myeloma Ovarian Cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: patients with either breast cancer, ovarian cancer or Multiple Myeloma, that did not receive any systemic therapy during the previous three months. (Hormonal therapy is accepted in case of breast cancer). For details of inclusion: see paragraph D4b.

Exclusion criteria

Exclusion criteria: Recent (3 months) systemic therapy. In more detail: see D5b.

Design outcomes

Primary

Measure	Time frame
Can we collect enough and adequate dendritic cells from the group of patients defined above, in our facility and using our culture system. For clarity: there will be no add back of the cells to patients in this study	—

Secondary

Measure	Time frame
not relevant.	—

Countries

Netherlands

Outcome results